Company Filing History:
Years Active: 2012-2015
Title: Inventor Spotlight: Scott Hayward Mayfield
Introduction
Scott Hayward Mayfield is an accomplished inventor based in Florissant, Missouri, known for his contributions to the field of radiopharmaceuticals. With a portfolio of five patents, Mayfield has made significant advancements in nuclear pharmacy technologies that enhance safety and efficiency in medical applications.
Latest Patents
One of Mayfield's notable recent inventions is the "Protective Shroud for Nuclear Pharmacy Generators." This protective shroud is designed to cover a radiation shield that surrounds a nuclear pharmacy generator, ensuring that the radiation shield components are adequately protected. The shroud features a tubular body that contains the radiation shield, allowing for a first opening for the radiation shield and a second opening that provides access into the shield.
Another significant patent is the "Holder and Tool for Radioisotope Elution System." This innovative holder is intended for a vial containing a sterile liquid used in a radiopharmaceutical elution system. It comprises a holder body with a top, an opposing bottom, and a vial chamber specifically shaped for receiving the vial. An access opening through the bottom aligns with the septum of the elution vial when inserted, facilitating efficient use. Notably, the cap of the holder is removably secured to enable selective opening and closing of the vial chamber.
Career Highlights
Scott Hayward Mayfield has built a distinguished career at Mallinckrodt, Inc., a leading provider in the medical sector. His work focuses on enhancing the safety and usability of nuclear pharmacy technologies, underscoring his commitment to innovation in healthcare. His patents reflect a deep understanding of the technical requirements needed for effective medical applications.
Collaborations
Throughout his career, Mayfield has collaborated with talented professionals, including his coworkers Kevin Robert Martz and Anthony K. Lewis. These partnerships contribute to the innovative atmosphere at Mallinckrodt, fostering the exchange of ideas that lead to groundbreaking advancements in the industry.
Conclusion
Scott Hayward Mayfield's contributions to the field of radiopharmaceuticals are notable. His innovative patents demonstrate a commitment to improving safety and efficiency in medical applications. As he continues to work at Mallinckrodt, he is likely to inspire future advancements that will benefit both practitioners and patients in the healthcare system.